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Abstract
Background: Hyperglycemia in pregnancy is a medical condition resulting from either pre-existing diabetes or
insulin resistance developed during pregnancy. This study aimed to determine the prevalence of hyperglycemia in
pregnancy and influence of body fat percentage and other determinants on developing hyperglycemia in
pregnancy among women in Arusha District, Tanzania.
Methods: A cross–sectional study was conducted between March and December 2018 at selected health facilities
in Arusha District involving 468 pregnant women who were not known to have diabetes before pregnancy. Blood
glucose was tested by Gluco-Plus™ using the World Health Organization criteria at fasting and 2 h after consuming
75 g of glucose dissolved in 300 ml of water. Body fat was measured using a bioelectric impedance analyzer, mid-
upper arm circumference using a regulated tape, weight using SECA™, blood pressure using a GT-868UF
Geratherm™ machine, and height using a stadiometer. Demographic and maternal characteristics were collected
through face to face interviews using a structured questionnaire.
Results: The participants’ mean age was 28 years (SD ± 6), mid-upper arm circumference 27 cm (SD ± 3.7), body fat
33.72% (SD ± 7.2) and pre-pregnancy body mass index 25.6 kg/m2 (SD ± 5.5). One-third of participants had mid-
upper arm circumferences ≥28 cm with 25% being overweight and 22.7% obese before pregnancy. Prevalence of
hyperglycemia in pregnancy was 16.2% (n = 76) of which 13% had gestational diabetes and 3.2% diabetes in
pregnancy. Hyperglycemia in pregnancy was significantly associated with body fat percentage (AOR 1.33; 95% CI:
1.22–1.44), family history of Type 2 diabetes mellitus (AOR 6.95, 95% CI: 3.11–15.55), previous delivery of babies ≥4
kg (AOR 2.3, 95% CI: 1.00–5.28), mid-upper arm circumference ≥ 28 cm (AOR 1.2, 95% CI: 1.09–1.32), and Type 2
diabetes mellitus symptoms (AOR 2.83, 95% CI: 1.53–6.92).
Conclusion: The prevalence of hyperglycemia in pregnancy was high, particularly among women with history of
delivering ≥4-kg babies, increased body fat, mid-upper arm circumference, symptoms and/or family history of Type
2 diabetes mellitus. These findings identify opportunities to further explore the utility of body fat percentage and
other determinants for rapid screening and management of hyperglycemia in pregnancy.
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Background
Hyperglycemia in pregnancy (HIP) is one of the most
common pregnancy-specific health challenges [1].
Hyperglycemia first detected at any time during preg-
nancy should be classified either as diabetes mellitus in
pregnancy (DIP) or gestational diabetes mellitus (GDM).
Hence, HIP is a result of either pre-existing diabetes or
insulin resistance developed during pregnancy, a condi-
tion known as gestational diabetes mellitus (GDM)
which is defined as impaired glucose tolerance first rec-
ognized during pregnancy [2–4]. This condition occurs
due to pregnancy-induced changes in maternal glucose
metabolism and insulin sensitivity, whereby demand for
insulin production on the mother’s pancreas increases as
the pregnancy proceeds [5]. In most instances, these
women can meet the increased insulin demand, but fail-
ure to accommodate results in poor glycemic control.
This condition may disappear spontaneously after deliv-
ery, but, if misdiagnosed and mismanaged, may lead to
persistent long-term health risks to the mother and the
child, such as predisposition to obesity and development
of Type 2 diabetes mellitus (T2DM) within five to 10
years postpartum [6].
Globally, the prevalence of GDM among women aged
20–49 years was estimated to be 17% affecting 21.4 mil-
lion live births with more than 90% cases occurring in
low- and middle-income countries [6]. Estimates suggest
that GDM ranges between 6 and 18% in East and West
Africa with pockets of higher prevalence (i.e., 19.5% in
urban areas of Tanzania) [7, 8]. Inaction on the HIP
agenda will lead to future high prevalence and contrib-
ute to an increased disease burden on the health system.
Considering the disproportionate rates of overweight/
obesity among Tanzanian pre-pregnant women in urban
(42%) and rural (21%) locations, localized considerations
are required [9]. Women with hyperglycemia are at high
risk of hypertension, abortion/miscarriage, and/or a
pregnancy resulting in a newborn who is large for gesta-
tional age (macrosomia), preterm birth, and/or incur
perinatal death [10]. A number of risk factors contribut-
ing to HIP include family history of DM, previous deliv-
ery to macrosomia or stillbirth, intrauterine fetal death
(IUFD), maternal obesity, and preterm delivery [11].
In addition to sedentary lifestyle, maternal height, diet-
ary factors, cigarette smoking, and extreme pregnancy
weight gain accompanied by high body fat accumulation
place women at risk of HIP. Body fat percentage can
alter body composition leading to pregnancy diabetes
and other complications, such as pregnancy induced
hypertension and predisposition of the newborn to over-
weight later in life [12–14]. It can also affect growth of
the fetus; therefore, assessment of change in body fat
content is important as predictive of both maternal and
child health [15]. Body mass index (BMI) is a commonly
used standard measure for assessing body fatness [16];
however, it does not distinguish between fat and lean
body mass [17]. The delay of onset of antenatal care
(ANC) means most women do not know their pre-preg-
nancy weight which makes it difficult to estimate BMI
and weight gain during pregnancy which is reported to
be strongly correlated with fat mass change [18]. This
pre-pregnancy metric is even more important because,
in addition to body fat and lean body mass, the fetal
mass and amniotic fluid constitute an unknown contri-
bution to total body mass of the mother which is indis-
tinguishable within the BMI calculation. Furthermore,
women, who are not obese by traditional weight criteria,
may have an increased percentage of body fat distributed
predominantly in the abdominal region, which leads to
increased risk of HIP [19]. Studies done with T2DM pa-
tients have identified that fat deposits within skeletal
muscle and liver cells is a major contributing factor to
insulin resistance; however, there is lack of evidence on
whether fat deposition during pregnancy adequately ex-
plains the acquisition of insulin resistance as a marker
for HIP [20, 21].
Few studies have assessed the effects of body fat on
development of GDM with most extant studies consider-
ing Caucasian and Asian populations [22, 23]. This vari-
ance requires redress as risks for HIP differ across
ethnic, geographic, and genetic lines due to differences
in body composition, lifestyles, genetic susceptibility, as
well as healthcare system capacities [24]. Some popula-
tions may have lower BMI but high rates of HIP. For ex-
ample, Asian populations tend to have a lower BMI, but
accumulate visceral fat and develop abdominal obesity
[25] which is positively associated with insulin resistance
and impaired β cell function [26, 27].
In addition to body fat percentage, MUAC has a
strong correlation with BMI [16] therefore it can be used
instead of BMI as a much simpler, cheaper anthropo-
metric measurement, which does not change signifi-
cantly during pregnancy. Hence, it may be a better
indicator of pregnancy body fat and nutrition status than
BMI [28]. MUAC does not need mathematical calcula-
tions, additional equipment, and regular equipment
standardization which are important considerations in
limited resource settings [29]. Furthermore, MUAC is
highly associated with GDM [30] which means that a
woman with a MUAC beyond the normal value is at in-
creased risk of GDM compared to the one with normal
MUAC value.
The current study was conducted in Arusha District,
which has a known high prevalence of T2DM (16.2%)
especially in urban (22.9%) compared to rural (9.9%)
areas [31], although this variance may, in part, reflect
undiagnosed and unmanaged HIP outside the urban
centres. This situation led to the need to determine the
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prevalence of HIP and its associated risk factors espe-
cially the less explored body fat percentage for possible
interventions to prevent short- and long-term adverse
effects to the mother and her newborn.
Methods
A cross-sectional study was conducted in urban areas of
Arusha District between March and December of 2018.
The study involved pregnant women attending antenatal
clinics at Ngarenaro and Kaloleni Health Centers in
Arusha District. The two centers were purposively se-
lected due to their central location and large numbers of
pregnant women (on average 40–100 per day) accessing
Ante-Natal Care (ANC) services from across the Dis-
trict, thereby representing the demographics of this pre-
dominantly urban patient population. The study
included women with gestational ages between 24 and
36 weeks anticipating delivery at one of the participating
centers. Pregnant women with previously diagnosed dia-
betes and selected conditions, such as sickle-cell anemia
or cancer, were excluded from the study. The aim, pro-
cedure, benefits, and negative effects of the study were
explained to all enrolled women agreeing to participate
and signed informed consents. The study was approved
by the Tanzania National Institute of Medical Research
(NIMR) with a reference number NIMR/HQ/R.8a/
Vol.IX/2694.
The eligible women were selected with assistance of
the nurse in-charge resulting in a total of 468 women
being involved in the study. Sample size was determined
in accordance with the formula for prevalence studies
[32]. Due to limited large-scale data on the prevalence of
HIP in Tanzania, 50% was used as prevalence in the for-
mula for maximum reality [33] with an assumed attrition
rate of 20%. Random sampling using a table of numbers
was used to select women to participate in the study and
due to the high number of pregnant women attending
ANC in the areas, 12 women were assessed per day. All
participants (100%, n = 468) completed fasting blood glu-
cose tests and face-to-face interviews using structured
questionnaires. In addition, nearly all (97.8%, n = 446) of
the participating women completed Oral Glucose Toler-
ance Test (OGTT) procedures.
Assessment of demographic characteristics and selected
risk factors for HIP
Recalled information respecting weight before preg-
nancy, first generation family history of T2DM, previous
history of GDM, symptoms of T2DM, and previous de-
livery of babies weighing ≥4 kg at birth were collected
through face-to-face interviews using a structured ques-
tionnaire. Other maternal characteristics, such as age,
perinatal and prenatal death, gravidity, education level,
occupation, marital status, and weight during the first
pre-natal visit, were obtained from the participants’
ANC records.
Laboratory tests for HIP
Women were required to fast overnight before capillary
blood was taken using a finger prick with a sterile lancet
after cleaning the site with an antiseptic alcohol swab.
Fasting blood glucose and 2 h OGTT following the con-
sumption of anhydrous glucose of 75 g dissolved in 300
ml of water [3, 34] were measured using Gluco-plus™
(Glucoplus Inc. 2323 Halpern, Ville St. Laurent, Quebec,
Canada). The capillary plasma glucose values obtained
were converted into venous plasma glucose using the re-
gression equation developed for diabetes screening in
the low resource areas where venous blood is challen-
ging [35]. Women whose fasting blood glucose levels
were ≥ 5.1 mmol/L were requested to return the next day
for another fasting glucose test. Women were classified
as having HIP if they met the criteria for DIP and GDM
which is fasting plasma glucose (5.1–6.9 mmol/l (92–
125 mg/dl), or a 2-h plasma glucose (8.5–11.0 mmol/l
(153–199 mg/dl) following a 75-g oral glucose load. The
1-h OGTT was not considered because there are no
established criteria for the diagnosis of diabetes based on
the 1-h post-load value and one reading is enough.
Hence a single blood draw after 2 h is more reasonable
than after every 1 hour [3]. In addition, DIP was classi-
fied by fasting plasma glucose ≥7.0 mmol/l (126 mg/ dl)
and/or 2-h plasma glucose ≥11.1 mmol/l (200mg/dl) fol-
lowing a 75 g oral glucose load [34]. Furthermore, all
women identified with HIP were referred to see the doc-
tor for further actions.
Anthropometric assessments
Mid-upper arm circumference (MUAC) was measured
using a non-stretchable tape and women were catego-
rized as normal with a MUAC of < 28 cm and over-
weight with MUAC ≥28 cm. Mid upper arm
circumference was used to supplement BMI due to its
relative stability during the course of pregnancy and high
correlation with pre-pregnancy BMI, making it a better
indicator of pre-pregnancy body fat and nutrition status
than the BMI [16, 36]. Weight was measured with min-
imal clothing and without shoes using a digital bath-
room weighing scale (SECA-Germany), placed on a flat
surface and recorded to the nearest 0.1 kg. Body fat per-
cent was determined using a bioelectric impedance
analyzer (Tanita TBF 105 Fat Analyzer™) which includes
adjustment for age, height, and sex. The body fat per-
centage was treated as a continuous variable and there
are no established classification criteria for pregnancy.
Blood pressure was measured using a GT-868UF Ger-
atherm™ machine and women were classified using the
blood pressure categories of systolic 130 to 139 mmHg
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or diastolic 80 to 89mmHg for Stage 1 hypertension and
systolic ≥140 mmHg or diastolic ≥90 mmHg for Stage 2
hypertension [37].
Data analysis
Data collected were analyzed using the Statistical Pack-
age for Social Science™ (SPSS) Version 20 and descrip-
tive statistics, such as frequency, mean and percentage,
were obtained. Chi-square test was used for comparing
the selected categorical variables between women with
and those without HIP. Blood glucose levels were di-
chotomized, and univariate analysis was done for the
variables associated with HIP to obtain crude odd ratios.
Multiple logistic regression analysis explored whether
different factors had significant association with HIP
where the quantitative variables such as body fat per-
cent, BMI and MUAC were treated as continuous vari-
ables. Statistical inference was based on 95% confidence
intervals (CIs) and significance at p value ≤0.05. Some
factors were potential confounders, hence they were in-
troduced into the model during the analysis, such as age,
and gestational age. The variables with missing data (i.e.,
BMI) were analyzed by “pairwise” deletion where the
statistical procedure used cases that contain some miss-
ing data. Hence, the entire case/respondent was not left
out of subsequent analyses for elements on which data
were complete. Other variables, which were missing due
to mistakes in recording, were traced back from the par-
ticipants as their phone numbers and other contacts
were recorded. Other missing data were traced from
ANC records available in the health center. Student’s t-
test was used to compare the means for HIP and non-
HIP groups for continuous variables, such as mean
OGTT and fasting glucose values.
Results
A total of 468 pregnant women participated in the study
at Ngarenaro and Kaloleni Health Centers in Arusha,
Tanzania. They were all black African by ethnicity. Most
were married (95.9%, n = 459), and over half had
attended primary school (58.8%, n = 275) and were self-
employed (55.8%, n = 261) primarily in small businesses
earning an average income of < 250,000 Tanzanian Shil-
lings (TSH) per month (approximately 110 American
dollars). The mean age of the women was 28 years (SD ±
5.84), of which 65.6% were ≥ 25 years old. The mean ges-
tational age at the start of ANC was 18 weeks (SD ±
5.62) and 28.5 weeks (SD ± 3.82) at the beginning of this
study where nearly two-thirds (62.2%, n = 354) were be-
yond 28 weeks gestation at time of entry to the study
with 50.4% (n = 236) reported as second or third gravid-
ity (Table 1).
The mean self-reported pre-gestational weight was 67
kg (SD ± 12.5). This weight was used to determine pre-
pregnancy BMI of the women in which 25.2% (n = 60)
were classified as overweight and 22.7% (n = 54) as
obese. The measured mean height was 159 cm (SD ±
6.3), body fat 33.7% (SD ± 7.2), and MUAC 27 cm (SD ±
3.8) in which 36.1% (n = 164) had MUAC ≥28 cm
(Table 2).
All pregnant women who participated in the study
(100%, n = 468) completed fasting blood glucose tests
and 97.8% (n = 446) underwent an OGTT. The preva-
lence of HIP was 16.2% (95% CI: 13–19.9) of which 3.2%
(n = 15) had DIP and 13% (n = 61) GDM using the
WHO [3] criteria. Among the women assessed, 10.9%
Table 1 Demographic and selected maternal characteristics of
pregnant women
Respondent Variables Frequency (n) Percent (%) Mean (±SD)
Education levels
Never went to school 8 1.7
Primary level 275 58.8




Married or Cohabiting 439 93.8
Divorced/Separated 13 2.8
Occupational status
Formally employed 46 9.8
Self employed 261 55.8
Unemployed 161 34.4




I don’t know 167 35.7
Age
<25 years 164 35.0 28 (SD ± 5.84)
≥25 years 304 65.0
Gestational age at first visit
<12 weeks 57 12.2
12–24 weeks 363 77.6 18 (SD ± 5.62)
25–36 weeks 48 10.2
Gestational age at study commencement
24–28 weeks 291 62.2 28 (SD ± 3.82)
>28 weeks 117 37.8
Gravidity
Prime 142 30.3
Second and third 236 50.4 3 (SD ± 1.20)
Fourth and above 90 19.2
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(n = 51) reported to have symptoms of T2DM, such as
extreme tiredness, diaphoresis (excessive sweating), and
polydipsia (excessive thirst) (Table 3).
The overall mean of fasting blood glucose was 4.5
mmol/L (SD ± 1.3), with the HIP sub-group having a
mean of 6.4 mmol/L (SD ± 1.5), yielding a significantly
higher (p < 0.001) mean compared to the non-HIP group
(4.2 mmol/L, SD ± 0.9). The overall mean for OGTT was
5.5 mmol/L (SD ± 1.06) and was significantly higher (p <
0.001) among the HIP (8.3 mmol/L, SD ± 1.3) compared
to the non-HIP group (5.5 mmol/L, SD ± 0.1) (Table 4).
The prevalence of HIP was significantly higher (p <
0.000) among women with a family history of T2DM
(44.9% vs 10.5%, p < 0.001); MUAC ≥28 cm (23.1% vs
12.4%, p = 0.003); previous delivery of an infant ≥4 kg
(47.1% vs 4.4%, p < 0.001); and symptoms of T2DM
(49.1% vs 12.2%, p < 0.001). The observed prevalence of
HIP did not differ significantly among women with his-
tories of prenatal or perinatal death, high blood pressure,
high maternal age, or smoking and alcohol intake habits
(p > 0.05) (Table 5).
The selected risk factors were analyzed using multiple
logistic regression analysis to determine their association
with HIP. A significant association was observed with in-
creased body fat percentage (AOR 1.33, 95% CI: 1.22–
1.44), family history of T2DM (AOR 6.95, 95% CI: 3.11–
15.55) and previous delivery of babies ≥4 kg (AOR 2.3,
95% CI: 1.00–5.28), and/or having any symptoms of
T2DM (AOR 2.83, 95% CI: 1.53–6.92) in the first model.
The second model replaced body fat percentage with
MUAC and the association remained consistently sig-
nificant in all factors of the first model with addition of
MUAC (AOR 1.2, 95% CI: 1.09–1.32) (Table 6).
Discussion
The current study was carried out to determine the
prevalence of HIP and influence of body fat percent and
other risk factors on development of HIP among women
in Arusha District. The overall prevalence of HIP was
found to be 16.2%, of which 3.2% had DIP and 13%
GDM according to WHO criteria [3]. Gestational dia-
betes mellitus is not the only form of hyperglycemia
which may first be detected during pregnancy as DIP is
a more severe form of HIP in which diagnostic glucose
levels are the same as those of non-pregnant adults [3].
Therefore, the prevalence of hyperglycemia in pregnancy
in this study combined GDM and DIP as it is important
to include pregnant women with pre-existing diabetes in
designing interventions. Moreover, DIP increases the
vulnerability to complications because of the degree of
hyperglycemia and the uncertainty as to whether the on-
set of hyperglycemia was prior to pregnancy or it devel-
oped during pregnancy [2]. This study provides evidence
for designing interventions like pre-pregnancy testing of
blood glucose levels, emphasis on health education to
improve health seeking behaviors among women of re-
productive age. In Tanzania, due to limited resources,
most women are not tested for glucose levels before
pregnancy. It is therefore important that HIP is consid-
ered to ensure thorough glucose control before concep-
tion, throughout pregnancy and postpartum for
prevention of diabetes in progressive pregnancies.
Hence, including DIP and GDM together may
strengthen the approach and allow recognition of gen-
eral prevalence of hyperglycemia to open dialogue on fu-
ture GDM approaches that align with global standards
for all women in Tanzania. The observed prevalence of
HIP may increase burden to the health system if no im-
mediate actions are taken. The need exists to explore
the associated modifiable risk factors including body fat
to enhance self-care practices and prevent poor preg-
nancy outcomes as well as T2DM later in life. A similar
study conducted in Tanzania using the same WHO [3]
criteria reported that the prevalence of GDM was 19.5
and 3% had DIP in Moshi Kilimanjaro Region which is
higher than the current study [8]. The differences in
Table 2 Anthropometric measurements of the pregnant
women
Variables tested Frequency (n) Percent (%) Mean (SD)
BMI (kg/m2) from self-reported pre-pregnancy weight
Underweight (< 18.5) 15 6.3
Normal (18.5–24.9) 109 45.8 25.5 (SD ± 6.3)
Overweight (25–29.9) 57 25.2
Obese (≥30) 48 22.7
MUAC
<28 cm = Normal 299 63.9 27 (SD ± 3.8)
≥28 cm = Above normal 169 36.1
Body fat percentage 33.4 (SD ± 7.8)
Self-reported pre-pregnancy weight (kg) 67 (SD ± 12.5)
Height (cm) 159 (SD ± 6.3)
Table 3 Laboratory tests for glucose and protein among
pregnant women






Having any symptoms of diabetes
Yes 51 10.9
No 417 89.1
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prevalence of hyperglycemia observed may be due to na-
ture of the diets, cultural differences in food prepar-
ation, and care during pregnancy which needs further
exploration. In addition, another similar study done
in India supported our findings on the consideration
of HIP in screening hyperglycemia during pregnancy
and reported that, HIP was prevalent in 18.9% of the
study population where by 16.3% had GDM and 2.6%
DIP [38].
The prevalence of HIP in the present study was signifi-
cantly associated with increased body fat percentage,
family history of T2DM, previous delivery of ≥4 kg ba-
bies, and reported symptoms of T2DM. When body fat
percentage was replaced by MUAC in the second model,
increased in MUAC was independently associated with
HIP. On other hand, BMI obtained from the recalled
pre-pregnancy weight was not significantly associated
with HIP even after been replaced for MUAC and/or
body fat percentage in the models, making it a weak de-
terminant of HIP. In this case, body fat percentage to-
gether with MUAC can be used instead of BMI as
determinants of HIP due to their independent associ-
ation with HIP. Moreover, the majority of the women in
the current study could not recall their pre-pregnancy
weight making it difficult to estimate their BMI. This
finding is supported by Mwanri et al. [30] who found
that BMI could not be estimated for most of the women,
as they could not recall their pre-pregnancy weight. An-
other study reported that less than half of the mothers
could recall their pre-gestational weight [39].
Although pre-gestational weight can be estimated with
a recorded weight within 15 weeks of pregnancy [39],
women in the current study started ANC with a mean
gestational age of 18 weeks; hence, their pre-pregnancy
weights were indeterminate. A similar study reported
that, since most of the women appeared late to the ANC
with a mean gestational age of 20 weeks, it was difficult
to obtain pre-gestational weight [36]. Hence, information
on changes in body fat content is required due to its in-
dependent association with HIP which is further sup-
ported in a previous report that the risk of GDM was
independently associated with high body fat percent,
similar to the findings in people with T2DM [23]. With
these associations, it would be important to utilize these
simple factors to identify pregnant women at risk for
HIP so that prevention measures, such as lifestyle modi-
fications, can be implemented to prevent poor preg-
nancy outcomes [40].
Women with a history of delivering babies ≥4 kg at
birth were at twice the risk of GDM compared to their
counterparts even after adjusting for body fat percent-
age, pre-pregnancy BMI, gestational age, and MUAC.
This finding reveals how maternal health status is the
determinant of health of the newborn. Another study
found that a previous history of delivering a baby weigh-
ing ≥4 kg was an independent predictor of developing
GDM [41]. This finding means that a woman with his-
tory of previous pregnancy, which resulted in a child
with a high birth weight, is at an increased risk of GDM
in progressive pregnancies [42].
The current study also reported that women with fam-
ily history of diabetes were at almost 7 times greater risk
of HIP compared to their non-affected counterparts
meaning that HIP can be influenced by genetic predis-
position and/or lifestyle practices, such as dietary and
low physical activities. Another study showed that GDM
is considered to result from interaction between genetic
and environmental risk factors [43]. Pregnancy triggers a
series of metabolic imbalances that lead to a diabetic
state in women who are already genetically predisposed
to develop diabetes [44]. Of note, GDM and T2DM
share a similar genetic background [45] which might be
a reason to why women with strong first-degree family
history of T2DM are at high risk of HIP. Hence, gen-
etic predispositions to T2DM or HIP should not be
ignored. Other studies concur with the current report
that family history of diabetes remained significantly
associated with GDM even after adjustment for other
co-variates [37, 46].
Nevertheless, some women with HIP reported having
one or more symptoms of T2DM, such as extreme tired-
ness, diaphoresis (excessive sweating), and polydipsia
Table 4 Mean blood glucose comparisons between women with and without HIP
Variables Tested Frequency(n) Mean SD P-value
Fasting blood glucose
General fasting blood glucose 468 4.5 ±1.3
Normal (< 5.1 mmol/L) 397 4.2 ±0.9 0.000*
HIP (≥5.1 mmol/L) 71 6.4 ±1.5
OGTT
General OGTT values 446 5.6 ±1.06
Normal (< 8.5 mmol/L) 436 5.5 ±0.1 0.000*
Glucose intolerance (≥8.5 mmol/L) 10 8.3 ±1.3
*significant
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(excessive thirst) and increased frequent urination.
These symptoms were found to have a strong independ-
ent association with HIP even after adjusting for MUAC,
BMI, gestational age and family history of T2DM. Con-
sidering the asymptomatic nature of HIP [19], these
women may have pre-existing T2DM which was not di-
agnosed before pregnancy because, 3.2% (n = 15) of the
women were found to have high cut off points which in-
dicated T2DM. This creates a need to promote pre-preg-
nancy preparation that include regular screening for
diabetes before conception for earlier efforts to prevent
the development of HIP. Hyperglycemia in pregnancy
has few symptoms and should be diagnosed by screening
during pregnancy [47]. Another study reported that
overt symptoms of HIP are rare and may be difficult to
distinguish from normal pregnancy symptoms creating a
need for confirmatory OGTT [19]. Hyperglycemia in
pregnancy can be influenced by first generation family
history of T2DM and, when undiagnosed and
Table 5 Comparison of selected characteristics between
women with and without HIP
Variable With HIP Without HIP P-value
MUAC
<28 cm (Normal) 37 (12.4%) 262 (87.7%) 0.003*
≥28 cm (overweight/obese) 39 (23.1%) 130 (76.9%)
BMI pre-pregnancy
Underweight and Normal 19 (15.3%) 105 (84.7%) 0.251
Overweight and Obese 24 (21.1%) 90 (78.9%)
Family history of diabetes
Yes 35 (44.9%) 43 (55.1%) 0.000*
No 41 (10.5%) 349 (89.5%)
Previous delivery to ≥4 kg baby
Yes 48 (47.1%) 54 (52.9%) 0.000*
No 10 (4.4%) 219 (95.6%)
Mother’s maternal age
<25 years 24 (14.4%) 143 (85.6%) 0.414
≥25 years 52 (17.3%) 249 (82.7%)
Symptoms of T2DM
Yes 25 (49.0%) 26 (51.0%)
No 51 (12.2%) 366 (87.8%) 0.000*
Prenatal death
Yes 10 (15.9%) 53 (784.1%) 0.467
No 48 (17.9%) 220 (82.1%)
Perinatal death
Yes 1 (10.0%) 9 (90.0%) 0.538
No 29 (20.1%) 115 (79.9%)
Alcohol intake
Yes 6 (19.4%) 25 (80.6%) 0.665
Never 63 (15.5%) 344 (84.5%)
Stopped during pregnancy 4 (25.0%) 12 (75.0%)
Smoking
Never 76 (16.2%) 390 (83.7%) 0.533
Stopped during pregnancy 0 (0.0%) 2 (100.0%)
*Significant
Table 6 Odd Ratios of select risk factors for hyperglycemia in
pregnancy
Univariate analysis




MUAC 1.16 (1.09–1.24) 0.000*
BMI 1.01 (0.99–1.03) 0.294
Symptoms of T2DM
No 1
Yes 6.9 (3.7–12.86) 0.000*
Family history of T2DM
No 1
Yes 6.93 (3.99–12.02) 0.000*
Previous delivery of ≥4 kg baby
No 1
Yes 5.9 (3.13–11.03) 0.000*
Preterm delivery
No 1
Yes 1.2 (0.366–3.826) 0.779
Multivariate analysis









MUAC NA 1.2 (CI: 1.09–1.32) 0.000*
Symptoms of T2DM
No 1 1
Yes 2.83(CI: 1.53–6.92) 0.023* 3.66(CI: 1.64–8.18) 0.002*
Family history of T2DM
No 1 1
Yes 6.95(CI: 3.11–15.55) 0.000* 6.04(CI: 3.04–12.01) 0.000*
Previous delivery to ≥4 kg babies
No 1 1
Yes 2.3(CI: 1.00–5.28) 0.049* 3.5(CI: 1.71–7.36) 0.001*
The univariate analysis also included periterm death, maternal age, gestational
age, and blood pressure with no significant association with HIP. Multivariate
analysis included family history of Type 2 diabetes mellitus (T2DM), previous
delivery of ≥4 kg babies, body fat percentage and MUAC in which body fat
was replaced by MUAC in model 2.The abbreviation NA means not applicable
in the particular model
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unmanaged, can lead into recurrent HIP in subsequent
pregnancies and/or T2DM later in life [6, 46]. Hence,
symptom clusters with other risk factors can be used for
identification of women who need screening for HIP
especially in low- and middle-income countries where
universal screening is not possible.
Limitation of the study
Some data were collected based on participants’ ability
to recall. For example, BMI was based on recall data
where almost half of the respondents could not report
their pre-pregnancy weight leading to missing data;
hence, interpretations on the rate of overweight and
obesity need to be done carefully. In addition, GDM was
tested by one out of two elevated glucose levels instead
of one out of three values as recommended [3].
Conclusions and recommendations
The prevalence of HIP was observed to be high in urban
areas of Arusha District and significantly associated with
family history of T2DM, increased MUAC, body fat per-
centage, and having one or more symptoms of T2DM.
The reported risk factors can be used to identify women
at risk of HIP early enough for earlier interventions to
be taken to prevent poor pregnancy outcomes especially
in resource poor settings where universal screening is
challenging. Modifiable risk factors, like body fat per-
centages for assessing nutrition status in pregnancy,
need to be further explored to identify the proper
methods for body fat estimation and develop criteria for
classification in pregnancy. Prevention strategies for HIP
need to be directed towards the knowledge and control
of the risk factors reported in this study and others for
promoting self-care before, during, and after pregnancy.
This proactive approach can potentially reduce the im-
pacts of non-modifiable risk factors, such as age and
genetic predisposition in developing HIP.
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